Interchange Capital Partners’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $100K | Sell |
10,665
-1,202
| -10% | -$11.3K | 0.02% | 278 |
|
|
2025
Q1 | $84.4K | Sell |
11,867
-2,584
| -18% | -$18.4K | 0.02% | 267 |
|
|
2024
Q4 | $163K | Sell |
14,451
-5,833
| -29% | -$65.9K | 0.06% | 242 |
|
|
2024
Q3 | $417K | Buy |
20,284
+139
| +0.7% | +$2.86K | 0.15% | 159 |
|
|
2024
Q2 | $456K | Buy |
20,145
+9,236
| +85% | +$209K | 0.17% | 146 |
|
|
2024
Q1 | $303K | Buy |
10,909
+670
| +7% | +$18.6K | 0.2% | 121 |
|
|
2023
Q4 | $311K | Buy |
10,239
+605
| +6% | +$18.4K | 0.23% | 106 |
|
|
2023
Q3 | $305K | Buy |
9,634
+735
| +8% | +$23.2K | 0.24% | 102 |
|
|
2023
Q2 | $363K | Sell |
8,899
-3,129
| -26% | -$128K | 0.28% | 87 |
|
|
2023
Q1 | $448K | Buy |
+12,028
| New | +$448K | 0.24% | 103 |
|
|
2022
Q4 | – | Sell |
-7,890
| Closed | -$441K | – | 151 |
|
|
2022
Q3 | $441K | Sell |
7,890
-838
| -10% | -$46.8K | 0.48% | 56 |
|
|
2022
Q2 | $451K | Sell |
8,728
-70
| -0.8% | -$3.62K | 0.51% | 59 |
|
|
2022
Q1 | $639K | Sell |
8,798
-582
| -6% | -$42.3K | 0.66% | 38 |
|
|
2021
Q4 | $1.11M | Buy |
9,380
+1,189
| +15% | +$141K | 1.11% | 14 |
|
|
2021
Q3 | $1.1M | Buy |
8,191
+437
| +6% | +$58.6K | 1.84% | 15 |
|
|
2021
Q2 | $1.26M | Sell |
7,754
-18,577
| -71% | -$3.01M | 1.94% | 12 |
|
|
2021
Q1 | $2.19M | Sell |
26,331
-3,169
| -11% | -$264K | 1.19% | 9 |
|
|
2020
Q4 | $1.6M | Buy |
+29,500
| New | +$1.6M | 0.87% | 16 |
|